Cetera Investment Advisers’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $60.4M | Buy |
696,767
+47,721
| +7% | +$4.57M | 0.06% | 302 |
|
|
2025
Q4 | $62.3M | Buy |
649,046
+8,749
| +1% | +$850K | 0.07% | 274 |
|
|
2025
Q3 | $61M | Buy |
640,297
+190,790
| +42% | +$17.5M | 0.07% | 265 |
|
|
2025
Q2 | $39.2M | Buy |
449,507
+6,681
| +2% | +$567K | 0.07% | 299 |
|
|
2025
Q1 | $39.8M | Buy |
442,826
+91,220
| +26% | +$8.16M | 0.08% | 265 |
|
|
2024
Q4 | $28.1M | Buy |
351,606
+12,776
| +4% | +$1.11M | 0.06% | 337 |
|
|
2024
Q3 | $30.5M | Sell |
338,830
-42,755
| -11% | -$3.6M | 0.07% | 299 |
|
|
2024
Q2 | $30M | Sell |
381,585
-25,667
| -6% | -$2.1M | 0.07% | 284 |
|
|
2024
Q1 | $35.5M | Buy |
407,252
+305,536
| +300% | +$26.1M | 0.08% | 241 |
|
|
2023
Q4 | $8.38M | Sell |
101,716
-23,845
| -19% | -$1.82M | 0.07% | 267 |
|
|
2023
Q3 | $9.84M | Sell |
125,561
-7,890
| -6% | -$660K | 0.08% | 222 |
|
|
2023
Q2 | $11.8M | Buy |
133,451
+5,388
| +4% | +$464K | 0.1% | 186 |
|
|
2023
Q1 | $10.3M | Buy |
128,063
+13,111
| +11% | +$1.07M | 0.09% | 207 |
|
|
2022
Q4 | $8.93M | Buy |
114,952
+48,807
| +74% | +$3.96M | 0.08% | 233 |
|
|
2022
Q3 | $5.34M | Sell |
66,145
-5,887
| -8% | -$529K | 0.11% | 201 |
|
|
2022
Q2 | $6.46M | Buy |
72,032
+7,794
| +12% | +$790K | 0.1% | 211 |
|
|
2022
Q1 | $7.13M | Buy |
64,238
+11,619
| +22% | +$1.23M | 0.1% | 216 |
|
|
2021
Q4 | $5.44M | Buy |
52,619
+7,605
| +17% | +$881K | 0.08% | 265 |
|
|
2021
Q3 | $5.64M | Buy |
45,014
+1,732
| +4% | +$224K | 0.09% | 246 |
|
|
2021
Q2 | $5.37M | Buy |
43,282
+2,859
| +7% | +$359K | 0.09% | 257 |
|
|
2021
Q1 | $4.78M | Sell |
40,423
-284
| -0.7% | -$33.3K | 0.09% | 232 |
|
|
2020
Q4 | $4.77M | Buy |
40,707
+22,814
| +128% | +$2.51M | 0.09% | 234 |
|
|
2020
Q3 | $1.86M | Sell |
17,893
-3,623
| -17% | -$364K | 0.15% | 162 |
|
|
2020
Q2 | $1.97M | Sell |
21,516
-59
| -0.3% | -$5.66K | 0.18% | 141 |
|
|
2020
Q1 | $1.95M | Buy |
21,575
+3,404
| +19% | +$362K | 0.24% | 117 |
|
|
2019
Q4 | $2.06M | Buy |
18,171
+1,633
| +10% | +$179K | 0.21% | 125 |
|
|
2019
Q3 | $1.79M | Buy |
16,538
+2,155
| +15% | +$225K | 0.22% | 120 |
|
|
2019
Q2 | $1.4M | Buy |
14,383
+2,359
| +20% | +$215K | 0.18% | 133 |
|
|
2019
Q1 | $1.1M | Sell |
12,024
-87
| -0.7% | -$7.79K | 0.15% | 158 |
|
|
2018
Q4 | $1.1M | Sell |
12,111
-466
| -4% | -$43.5K | 0.18% | 138 |
|
|
2018
Q3 | $1.24M | Buy |
12,577
+9,810
| +355% | +$907K | 0.18% | 138 |
|
|
2018
Q2 | $237K | Buy |
2,767
+7
| +0.3% | +$585 | 0.04% | 360 |
|
|
2018
Q1 | $221K | Buy |
2,760
+54
| +2% | +$4.45K | 0.04% | 351 |
|
|
2017
Q4 | $217K | Sell |
2,706
-49
| -2% | -$3.92K | 0.04% | 374 |
|
|
2017
Q3 | $214K | Buy |
+2,755
| New | +$229K | 0.05% | 359 |
|
Other funds holding MDT
VCM
VPM
Cetera Investment Advisers's MDT Position: Q1 2026 in Review
Cetera Investment Advisers increased its Medtronic (MDT) stake by 7.4% in Q1 2026, buying an estimated $4.57M and bringing the position to 696,767 shares worth $60.4M. The position accounts for 0.06% of the portfolio, ranked #302.
Cetera Investment Advisers first reported a position in MDT in Q3 2017 and has held it in 35 quarters since. The position peaked at $62.3M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Cetera Investment Advisers held 696,767 shares of Medtronic worth $60.4M as of Q1 2026.
- Cetera Investment Advisers bought 47,721 Medtronic shares in Q1 2026, an estimated $4.57M.
- Medtronic made up 0.06% of Cetera Investment Advisers's portfolio in Q1 2026, its #302 holding.
- Cetera Investment Advisers first reported a position in Medtronic in Q3 2017 and has held it in 35 quarters since.
- Cetera Investment Advisers's Medtronic position peaked at $62.3M in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.